Literature DB >> 18357354

[Relationship between gestational diabetes and metabolic syndrome].

Cecilia Ferrada1, Marta Molina, Luis Cid, Gisela Riedel, Cristina Ferrada, Rodrigo Arévalo.   

Abstract

BACKGROUND: The metabolic syndrome (MS) is associated to a significant increase in the risk of diabetes, coronary heart disease and stroke, resulting in a 5-fold increase of the cardiovascular death rate. AIM: To determine the relationship between gestational diabetes (GD) and the development of MS at the end of puerperal period. PATIENTS AND METHODS: We conducted a case-control study in the Curanilahue Hospital, in southern Chile, including 58 women with GD during their pregnancy, studied in day 42 of their puerperal period (study group) and 58 puerperal women from the same hospital, who had a physiological pregnancy (control group). Triglycerides, HDL cholesterol, fasting and post prandial blood glucose levels, blood pressure, waist circumference, weight and height were measured. MS was diagnosed using the National Cholesterol Education Program (NCEP - ATP III) criteria.
RESULTS: Mean weight, body mass index, waist circumference, blood glucose and triglycerides were significantly higher in the study group and HDL cholesterol was significantly lower in the control group.
CONCLUSIONS: These results suggest a significant relationship between GD and the occurrence of MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357354     DOI: /S0034-98872007001200006

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Correlates of the metabolic syndrome among a sample of women in the San Juan Metropolitan area of Puerto Rico.

Authors:  Ana Patricia Ortiz; Erick Suárez; Giovanna Beauchamp; Josefina Romaguera; Marievelisse Soto-Salgado; Cynthia M Pérez
Journal:  Metab Syndr Relat Disord       Date:  2010-06       Impact factor: 1.894

Review 2.  Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra Lassi; Anna Ali; Margaret Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Rev Endocr Metab Disord       Date:  2020-10-27       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.